IPCI.H — Intellipharmaceutics International Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Intellipharmaceutics International, fiscal year end - November 30th, USD millions except per share, conversion factor applied.

	2018 November 30th	2019 November 30th	2020 November 30th	2021 November 30th	2022 November 30th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	6.64	0.065	0.202	0.772	0.084
Net Total Accounts Receivable
Net Total Receivables	1.24	0.953	1.05	0.268	0.269
Total Inventory
Prepaid Expenses
Total Current Assets	8.72	1.52	1.48	1.1	0.493
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.76	2.27	1.91	0.994	0.94
Other Long Term Assets
Total Assets	11.5	3.8	3.39	2.1	1.43
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	5.31	7.49	9.7	10.3	12
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	7.37	7.49	9.7	10.3	12
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	4.1	-3.69	-6.31	-8.16	-10.6
Total Liabilities & Shareholders' Equity	11.5	3.8	3.39	2.1	1.43
Total Common Shares Outstanding